project
H-Optimus-0 - An open-source pathology AI model from the French startup Bioptimus.
H-Optimus-0 is the world's largest open-source AI model for pathology, released by the French startup Bioptimus. The model has 1.1 billion parameters and was trained on a proprietary dataset containing 500... from 4,000 clinical practices.
What is H-Optimus-0?
H-Optimus-0 is the world's largest open-source AI foundational model for pathology, released by the French startup Bioptimus. The model boasts 1.1 billion parameters and was trained on a proprietary dataset containing hundreds of millions of images extracted from over 500,000 histopathological slides across 4,000 clinical practices. H-Optimus-0 achieves state-of-the-art performance on several key diagnostic tasks, including identifying cancer cells and detecting genetic abnormalities in tumors.
Main functions of H-Optimus-0
- Powerful feature extractionH-Optimus-0 can extract powerful features from histological images, which can be used for a variety of downstream applications, such as mutation prediction, survival analysis, or tissue classification.
- High-precision diagnosticsH-Optimus-0 achieves state-of-the-art performance in critical diagnostic tasks, including identifying tissue types, tissue characteristics, and detecting the presence of biomarkers or metastasis of cancer types.
- Training on large datasetsThe model was trained on a massive dataset of over 500,000 pathological slides, covering human tissues from different body regions, ensuring the model's generalization ability.
- Open source availabilityH-Optimus-0 is an open-source model that researchers can use to accelerate the development of novel digital pathology models and promote collaboration among researchers, clinicians, and developers.
The technical principle of H-Optimus-0
- Vision TransformerH-Optimus-0 is a visual transformer model with 1.1 billion parameters. A visual transformer is a model based on the Transformer architecture, initially used for natural language processing tasks and later successfully applied to computer vision. It can segment images into multiple patches, treating them as sequential data and capturing long-range dependencies and global features within the image.
- Self-supervised learning frameworkThe model is trained using the DINOv2-based self-supervised learning framework. DINOv2 is an advanced self-supervised learning method that enables the model to automatically learn feature representations of images through comparative learning and other methods, even without labeled data.
- Large-scale proprietary datasetsH-Optimus-0 was trained on a dataset of over 500,000 H&E-stained pathological slides, from which hundreds of millions of tiles were extracted. The data covers human tissues from different body regions and exhibits significant diversity.
- Data preprocessingDuring training, the images were standardized, including converting them into tensors and normalizing them. This helps improve the training efficiency and stability of the model.
H-Optimus-0 project address
- Project official website:https://www.bioptimus.com/news/bioptimus-launches-h-optimus-0
- Github repository:https://github.com/bioptimus/releases/tree/main/models/h-optimus/v0
- HuggingFace model library:https://huggingface.co/bioptimus/H-optimus-0
Application scenarios of H-Optimus-0
- Pathological diagnosis:H-Optimus-0 can assist pathologists in making faster and more accurate diagnoses, especially in identifying cancer cells and detecting genetic abnormalities in tumors.
- Biomarker detection:The model can detect the presence of biomarkers, which is crucial for the early diagnosis and treatment of cancer.
- Organizational Classification:H-Optimus-0 can be used to identify and classify different types of tissues, and is suitable for pathological research and clinical practice.
- Drug development:The model can be used for AI-driven research and drug development, supporting the discovery and development of new therapies by analyzing pathological images.
- Survival Analysis:H-Optimus-0 can be used to predict patient survival time and treatment response, and is suitable for personalized medicine and treatment planning.